PATRIA GONZALEZ: Open Payments
NPI 1730111402 · NEW YORK, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,170 in 82 payments from 23 companies in 2025. Trend: 2023 $751 · 2024 $1,759 · 2025 $2,170
Food & beverage: $2,077Education: $93
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 18 | $458 |
| GlaxoSmithKline, LLC. | 11 | $206 |
| PFIZER INC. | 4 | $201 |
| Astellas Pharma US Inc | 4 | $192 |
| Amgen Inc. | 4 | $111 |
| Madrigal Pharmaceuticals | 3 | $102 |
| Exact Sciences Corporation | 4 | $101 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 5 | $93 |
| Bayer Healthcare Pharmaceuticals Inc. | 4 | $89 |
| Aimmune Therapeutics, Inc. | 3 | $81 |
Products named: QULIPTA, TRELEGY ELLIPTA, NURTEC ODT, UBRELVY, REZDIFFRA, Veozah, RELISTOR, Kerendia.
Industry payments across NY — which companies pay providers there.
